Total Funding
48
67
Total FundingDebt Financing raised
Growth Score
26 pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
102094
Apie Therapeutics develop a portfolio of anti-fibrosis therapies to bring improved health outcomes for patients.
- Esther M. Alegria: Chief Innovation OfficerPast Role: Apie Therapeutics, Chief Executive Officer & Founder
Seth Hetherington: Chief Medical Officer & Board of DirectorPast Role: Genocea Biosciences, Chief Medical Officer
About the Company
Apie Therapeutics develop and commercialize novel Apelin Receptor biased agonist drug therapies, activating the Apelinergic System focused on the promising therapy targets of the Apelinergic System.
Women Founded
